Navigation Links
Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
Date:7/10/2008

ny's scientific and commercial vision, clinical development plans to proof-of-concept, and development milestones of select programs in clinical development. Some of the programs discussed included the following:

-- MDX-1106 (ONO-4538) is a fully human anti-PD-1 antibody in development with Ono Pharmaceuticals, Inc. for solid tumors. Preliminary data of anti- tumor activity in multiple tumor types from an ongoing Phase 1 trial were previously reported at a recent medical conference. A multi-dose Phase 2 study in solid tumors is expected to begin in 2008. A separate Phase 1 trial for hepatitis C viral infection is ongoing, with data expected in 2009.

-- MDX-1100 is a fully human antibody that targets IP-10, a chemokine that promotes the recruitment of pro-inflammatory cells that can cause tissue damage in rheumatoid arthritis and inflammatory bowel diseases. MDX-1100 represents a breakthrough mechanism of action for inflammatory disease and is being investigated in separate Phase 2 proof-of-concept trials for ulcerative colitis and rheumatoid arthritis. Interim data from these trials are expected in 2009.

-- MDX-1401 is a fully human antibody that targets CD30, a member of the TNF family expressed on CD30-positive lymphomas, including Hodgkin's lymphoma. MDX-1401 is a second-generation antibody enhanced for improved antibody effector function over the parental anti-CD30 antibody, MDX-060. Preliminary data from an ongoing Phase 1 trial of MDX-1401 is expected in 2008 at a medical conference, with final data expected in 2009.

-- MDX-1342 is a fully human antibody with enhanced antibody effector function that selectively binds to CD19, a molecule expressed on a broad range of B-cell malignancies. MDX-1342 also induces the depletion and elimination of B-cells for inflammatory disease indications. Phase 1 trials in chronic lymphocytic leukemia and rheumatoid arthritis are ongoing with data expected in 2009.

-- MDX-1411 is a fully human a
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
7. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
8. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
9. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
10. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
11. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... BETHLEHEM, Pa. , Nov. 21, 2014 /PRNewswire/ ... drug eluting devices, has developed and manufactured a ... Institute (LPRI), the Research and Development arm of ... Vice President of Project Management at Particle Sciences, ... Particle Sciences utilizing our material sciences and modeling ...
(Date:11/22/2014)... , Nov. 21, 2014 Many ... Undoubtedly, the growing influence of patients in the ... marketing interactions. Now, more than ever, understanding how ... for medical products is essential. ... Practices, LLC, benchmarked companies spent about two-thirds of ...
(Date:11/21/2014)... COLLEGE PARK, Md. , Nov. 21, 2014 /PRNewswire-USNewswire/ ... Engineering today will host the ceremonial groundbreaking of the ... Maryland, College Park. The new building will cultivate transformative ... human health.  Taking place at 10:00 a.m. ... building in the Paint Branch Parking Lot, adjacent to ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4
... October 25, 2011 International medical ... (NASDAQ OMX Stockholm: SECT B) , announces ... University Hospitals (UH) in Cleveland.   UH and ... medical imaging with the goals of improving patient care, ...
... SUNNYVALE, Calif., Oct. 25, 2011 ... premier radiation oncology company, today announced that the U.S. ... 510(k) clearance to market the Dose Control System (DCS), ... system performance.   The TomoTherapy System revolutionized ...
Cached Medicine Technology:Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland 2Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland 3Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System 2Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System 3
(Date:11/22/2014)... PrettyTailor , an outstanding dress ... big promotion. Customers can buy new dresses at its ... visit its website. , As a matter of fact, ... It mainly provides four types of wedding outfits, including ... girl dresses. It also provides a variety of occasion ...
(Date:11/22/2014)... is a famous brand in the bamboo flooring industry. ... bamboo mats ; the new models are offered now ... According to the sales manager of BambooFlooringChina.com, Bamboo is a ... resource. Their bamboo mats are 100% made from natural bamboo. ... bamboo with caramel bamboo strips. , “Bamboo mats ...
(Date:11/22/2014)... Discount-Dress.com is an important company ... is to increase the company’s online market share by a ... of bridesmaid dresses and announced a bridesmaid dress promotion for ... Dec. 30, 2014. All the dresses from this company are ... In fact, Discount-Dress.com is very good at manufacturing wedding dresses. ...
(Date:11/22/2014)... New York, New York (PRWEB) November 22, 2014 ... use of power morcellators ( http://www.morcellatorlawsuit2015.com ) in ... than 450 new signatures since the end of October, ... people had signed the petition as of November 21st, ... October 31st, when 86,042 supporters had signed on to ...
(Date:11/22/2014)... New York, New York (PRWEB) November 22, 2014 ... been filed on behalf of patients who allegedly developed ... move forward in the federal multidistrict litigation now underway ... Liebhard LLP reports. According to court documents, the litigation ... at 10:00 a.m. The Court has directed Lead Counsel ...
Breaking Medicine News(10 mins):Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3
... $12 million grant from the National Institutes of Health ... medication of choice for preventing migraines in children and ... and adolescents in the United States, with an annual ... FDA-approved medication to prevent childhood migraines and there are ...
... experience more chronic musculoskeletal pain, suggests a new study led ... women over the age of 18 were surveyed on their ... the analysis were fibromyalgia, sciatica, chronic neck pain, chronic back ... all over the body. Results showed that women who ...
... Pediatricians in Appalachia are less likely than doctors in ... the human papillomavirus (HPV) vaccine, according to a new study. ... most important risk factor for cervical cancer and studies ... cancer and to die from it than women living elsewhere. ...
... long been an attractive class of drug candidates because ... potential side effects. Dr. Andrei Yudin, Professor, Department ... and effective process that makes linear peptides circular, which ... effectively and increase their stability compared to linear peptides. ...
... By Serena Gordon HealthDay Reporter , TUESDAY, ... colon cancer screening earlier than women, new research suggests. ... have potentially precancerous lesions (also called polyps or adenomas) in ... percent of women -- and to have them at an ...
... documenting patients, preferences for care at the end of life ... A new study published today in the Journal of ... physicians about end-of-life care and have an advance directive in ... do not have these discussions and documents. The study ...
Cached Medicine News:Health News:Cincinnati Children's earns $12 million NIH grant to test migraine prevention medicines 2Health News:Study shows link between smoking and chronic pain in women 2Health News:Pediatricians in Appalachia less likely to recommend HPV vaccine 2Health News:Pediatricians in Appalachia less likely to recommend HPV vaccine 3Health News:OGI and MaRS Innovation invest in peptide therapeutics 2Health News:Do Men Need Colon Cancer Screening Earlier Than Women Do? 2Health News:Do Men Need Colon Cancer Screening Earlier Than Women Do? 3
The Dolphin Medical 2150 Pulse Oximeter consists of the Dolphin ONE OEM 701 Module technology, (1) extension cable, and (1) oximetry sensor to non-invasively calculate the functional saturation of ar...
All-in-One Fingertip Oximeter...
... The Invacare Sleep Printing ... specifically designed to address ... a device that can ... conducting overnight screening for ...
The reliable and easy-to-use 3900/P pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
Medicine Products: